MLchartDataset catalogue

Karenitecin

Term · Oncology and biomedicine · MLC-T-ONC-004610

A drug being studied in the treatment of cancer. It is a type of topoisomerase inhibitor. It is related to the anticancer drug camptothecin.

Table 1. Record
IdentifierMLC-T-ONC-004610
FieldOncology and biomedicine
ReferencesNCI Dictionary of Cancer Terms
Record as JSON 
{
  "id": "MLC-T-ONC-004610",
  "term": "Karenitecin",
  "field": "Oncology and biomedicine",
  "definition": "A drug being studied in the treatment of cancer. It is a type of topoisomerase inhibitor. It is related to the anticancer drug camptothecin.",
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/karenitecin/"
}

Record 9,729 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.